Loading Events

Hypertrophic Cardiomyopathy Lunch & Learn Series

July 13, 2023

12:00 pm CDT -1:00 pm CDT

Join us for a 4 part lunch and learn series on hypertrophic cardiomyopathy on the following days:

  • Thursday, July 13
  • Thursday, July 20
  • Thursday, July 27
  • Thursday, Aug 3

Supported by Bristol-Myers Squibb.

Learning Objectives

Hypertrophic Cardiomyopathy: Novel Treatments
    1. Identify characteristics of nonobstructive and obstructive HCM
    2. Describe the mechanism of action of cardiac myosin inhibitor
    3. Examine current literature and research into novel HCM treatment/s
    4. Analyze best clinical practice scenarios
Hypertrophic Cardiomyopathy: Patient Access and Team-Based Care
    1. Discuss access considerations for novel HCM treatments
    2. Explain potential barriers and related solutions to prescribing a cardiac myosin inhibitor, including prior authorizations and specialty pharmacy considerations
    3. Compare team-based approaches for successful medication administration in clinical setting, pharmacy, and home
    4. List the follow-up echocardiography requirements for HCM management
Hypertrophic Cardiomyopathy: Patient Adherence
    1. Describe the drug administration pathway from initiation to maintenance
    2. Discuss signs and symptoms that signify a needed dose adjustment
    3. Describe patient HCM treatment journey
    4. Assess team-based care scenarios for improving outcomes for patients taking novel medications
Hypertrophic Cardiomyopathy: Ask the Experts
    1. Review highlights of team-based care approach to ordering and administering novel HCM pharmaceutical therapy
    2. Using case-based scenarios, identify best practices for prescribing and administering novel medications for HCM
    3. Discuss how to maximize effective communications in team-based care
    4. Describe effective strategies for shared decision-making for patients with HCM and their family